These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25115129)

  • 1. Human papillomavirus: the fundamentals of HPV for oral health care providers.
    Ciarrocca K; Jackson LL; De Rossi SS
    Tex Dent J; 2014 May; 131(5):366-74. PubMed ID: 25115129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus: the fundamentals of HPV for oral health care providers.
    Ciarrocca K; Jackson LL; De Rossi SS
    J Calif Dent Assoc; 2013 May; 41(5):349-55. PubMed ID: 23795520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
    Osazuwa-Peters N
    Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving adolescent health: focus on HPV vaccine acceptance.
    Zimet GD
    J Adolesc Health; 2005 Dec; 37(6 Suppl):S17-23. PubMed ID: 16310137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Rosenquist K
    Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human papillomavirus in nongenital cancers.
    Zandberg DP; Bhargava R; Badin S; Cullen KJ
    CA Cancer J Clin; 2013 Jan; 63(1):57-81. PubMed ID: 23258613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
    Ryerson AB; Peters ES; Coughlin SS; Chen VW; Gillison ML; Reichman ME; Wu X; Chaturvedi AK; Kawaoka K
    Cancer; 2008 Nov; 113(10 Suppl):2901-9. PubMed ID: 18980273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against human papillomavirus for the prevention of cervical cancer].
    Quint WG; ter Harmsel WA; van Doorn LJ
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of human papillomavirus vaccination in Nordic countries.
    Sander BB; Rebolj M; Valentiner-Branth P; Lynge E
    Vaccine; 2012 Feb; 30(8):1425-33. PubMed ID: 22154773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccine: a paradigm shift for pediatricians.
    Jenson HB
    Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
    Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
    Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health issues related to HPV vaccination.
    Hershey JH; Velez LF
    J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.